Skip to content

Medical Cannabis and Cannabinoids

ISSN 2504-3889

3 papers in the library · publishing 2024-2025

Papers

Sort Most recent Most cited

The Individual and Interactive Effects of Alpha-Pinene and Delta-9-Tetrahydrocannabinol in Healthy Adults

Medical Cannabis and Cannabinoids June 25, 2025 Lakshmi Kumar, Tory R. Spindle, C. Austin Zamarripa et al.

Introduction: Cannabis contains hundreds of chemical constituents beyond delta-9-tetrahydrocannabinol (Δ9-THC), which is thought to be the primary driver of most of its acute pharmacodynamic effects. The entourage effect theory asserts that the pharmacological and therapeutic effects of cannabis are not solely attributable to Δ9-THC but are influenced by other constituents, such as minor...

Cannabis and Anxiety: A Critical Review

Medical Cannabis and Cannabinoids February 23, 2024 Alexander Beletsky, Cherry Liu, Bryson Lochte et al.

Abstract Introduction: Cannabis has been reported to have both anxiogenic and anxiolytic effects. Habitual cannabis use has been associated with anxiety disorders (AD). The causal pathways and mechanisms underlying the association between cannabis use (CU)/cannabis use disorder (CUD) and anxiety remain unclear. We examined the literature via a systematic review to investigate the link between...

Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill

Medical Cannabis and Cannabinoids February 13, 2024 Charles N. Zawatsky, Sara Mills-Huffnagle, Corinne M. Augusto et al.

Background: In this review, we summarize current scientific knowledge on psychoactive cannabinoids synthesized from cannabidiol (CBD) and sold in the semi-legal market established in response to the passage of the US Agriculture Improvement Act of 2018, commonly known as the 2018 Farm Bill. The discussion focuses on recent developments that suggest this unregulated market may be fertile ground...